Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer

International Journal of Antimicrobial Agents

Volumn 42, Issue 5, 2013, Pages 403-409

  Ha, Young Eun ^a   Kang, Cheol In ^a   Cha, Min Kyeong ^b   Park, So Yeon ^a   Wi, Yu Mi ^a   Chung, Doo Ryeon ^a   Peck, Kyong Ran ^a   Lee, Nam Yong ^a   Song, Jae Hoon ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

Author keywords

lactamase; Bacteraemia; Cancer; Escherichia coli; Extended spectrum; Treatment outcome

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE CTX M; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; IMMUNOSUPPRESSIVE AGENT; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIGECYCLINE; TOBRAMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; BACTERIUM ISOLATION; BLOODSTREAM INFECTION; CANCER PATIENT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; ESCHERICHIA COLI INFECTION; FEMALE; GRAM NEGATIVE SEPSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEPTIC SHOCK; SURGERY;

BACTERAEMIA; CANCER; ESCHERICHIA COLI; EXTENDED-SPECTRUM Β-LACTAMASE; TREATMENT OUTCOME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; COHORT STUDIES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84885428877     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.07.018     Document Type: Article

References (28)

1. Y.E. Ha, J.H. Song, W.K. Kang, K.R. Peck, D.R. Chung, and C.I. Kang Clinical factors predicting bacteremia in low-risk febrile neutropenia after anti-cancer chemotherapy Support Care Cancer 19 2011 1761 1767
2. J. Rodríguez-Baño, E. Picón, P. Gijón, J.R. Hernández, M. Ruíz, and C. Peña Spanish Network for Research in Infectious Diseases (REIPI), Community-onset bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: risk factors and prognosis Clin Infect Dis 50 2010 40 48
3. J.D. Pitout, and K.B. Laupland Extended-spectrum β-lactamase- producing Enterobacteriaceae: an emerging public-health concern Lancet Infect Dis 8 2008 159 166
4. R. Ben-Ami, J. Rodríguez-Baño, H. Arslan, J.D. Pitout, C. Quentin, and E.S. Calbo A multinational survey of risk factors for infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in nonhospitalized patients Clin Infect Dis 49 2009 682 690
5. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
6. J.W. Chow, and V.L. Yu Combination antibiotic therapy versus monotherapy for Gram-negative bacteraemia: a commentary Int J Antimicrob Agents 11 1999 7 12
7. N.D. Friedman, K.S. Kaye, J.E. Stout, S.A. McGarry, S.L. Trivette, and J.P. Briggs Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections Ann Intern Med 137 2002 791 797
8. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. Document M100-S21. Wayne, PA: CLSI; 2011.
9. J. Kim, Y.M. Lim, I. Rheem, Y. Lee, J.C. Lee, and S.Y. Seol CTX-M and SHV-12 β-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea FEMS Microbiol Lett 245 2005 93 98
10. S.H. Lau, S. Reddy, J. Cheesbrough, F.J. Bolton, G. Willshaw, and T. Cheasty Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing J Clin Microbiol 46 2008 1076 1080
11. C.I. Kang, D.R. Chung, K.S. Ko, K.R. Peck, and J.H. Song Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy Ann Hematol 91 2012 115 121
12. E.M. Trecarichi, M. Tumbarello, T. Spanu, M. Caira, L. Fianchi, and P. Chiusolo Incidence and clinical impact of extended-spectrum-β-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies J Infect 58 2009 299 307
13. C. Gudiol, F. Tubau, L. Calatayud, C. Garcia-Vidal, M. Cisnal, and I. Sánchez-Ortega Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes J Antimicrob Chemother 66 2011 657 663
14. M. Arnan, C. Gudiol, L. Calatayud, J. Liñares, M.Á. Dominguez, and M. Batlle Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies Eur J Clin Microbiol Infect Dis 30 2011 355 360
15. C. Gudiol, L. Calatayud, C. Garcia-Vidal, J. Lora-Tamayo, M. Cisnal, and R. Duarte Bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome J Antimicrob Chemother 65 2010 333 341
16. J.A. Lee, C.I. Kang, E.J. Joo, Y.E. Ha, S.J. Kang, and S.Y. Park Epidemiology and clinical features of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae Microb Drug Resist 17 2011 267 273
17. M.J. Schwaber, and Y. Carmeli Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis J Antimicrob Chemother 60 2007 913 920
18. C.I. Kang, Y.K. Sung, K.H. Lee, K.T. Lee, and J.K. Lee Clinical impact of inappropriate initial antimicrobial therapy on outcome in bacteremic biliary tract infections Scand J Infect Dis 45 2013 227 234
19. W.B. Park, K.D. Lee, C.S. Lee, H.C. Jang, H.B. Kim, and H.S. Lee Production of C-reactive protein in Escherichia coli-infected patients with liver dysfunction due to liver cirrhosis Diagn Microbiol Infect Dis 51 2005 227 230
20. P. Povoa, L. Coelho, E. Almeida, A. Fernandes, R. Mealha, and P. Moreira C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study Eur Respir J 25 2005 804 812
21. C.I. Kang, J.H. Song, D.R. Chung, K.R. Peck, K.S. Ko, and J.S. Yeom Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum β-lactamase-producing Escherichia coli Int J Antimicrob Agents 36 2010 284 287
22. J.D. Pitout, D.B. Gregson, L. Campbell, and K.B. Laupland Molecular characteristics of extended-spectrum-β-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections Antimicrob Agents Chemother 53 2009 2846 2851
23. J. Rodríguez-Baño, M.D. Navarro, L. Romero, M.A. Muniain, M. de Cueto, and M.J. Ríos Bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge Clin Infect Dis 43 2006 1407 1414
24. J. Rodríguez-Bano, J.C. Alcalá, J.M. Cisneros, F. Grill, A. Oliver, and J.P. Horcajada Community infections caused by extended-spectrum β-lactamase-producing Escherichia coli Arch Intern Med 168 2008 1897 1902
25. R. Ben-Ami, M.J. Schwaber, S. Navon-Venezia, D. Schwartz, M. Giladi, and I. Chmelnitsky Influx of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital Clin Infect Dis 42 2006 925 934
26. M.Y. Lee, H.J. Choi, J.Y. Choi, M. Song, Y. Song, and S.W. Kim Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea J Infect 60 2010 146 153
27. D.A. Boyd, S. Tyler, S. Christianson, A. McGeer, M.P. Muller, and B.M. Willey Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum β-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada Antimicrob Agents Chemother 48 2004 3758 3764
28. J. Rodríguez-Baño, E. Picón, P. Gijón, J.R. Hernández, J.M. Cisneros, and C. Peña Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-β-lactamase- producing Escherichia coli J Clin Microbiol 48 2010 1726 1731